Cellavision AB 

€11.02
10
-€0.22-1.96% Friday 19:46

Statistics

Day High
11.44
Day Low
11.02
52W High
17.94
52W Low
10.66
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.3%
Dividend
0.25

Upcoming

Dividends

2.3%Dividend Yield
May 26
€0.25
May 25
€0.23
May 24
€0.19
May 23
€0.2
May 22
€0.19
10Y Growth
4.57%
5Y Growth
27.79%
3Y Growth
7.92%
1Y Growth
10.54%

Earnings

17JulExpected
Q4 2025
Q1 2026
Next
0.08
0.11
0.14
0.17
Expected EPS
0.12910082952
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow C26.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap6.62B
Bio-Rad Laboratories offers digital imaging systems in clinical diagnostics, competing in the digital cell morphology space with Cellavision.
Danaher
DHR
Mkt Cap121.74B
Danaher, through its subsidiaries like Beckman Coulter, provides hematology analyzers and related laboratory equipment, directly competing with Cellavision's digital microscopy and image analysis technologies.
Bruker
BRKR
Mkt Cap6.53B
Bruker Corporation offers microscopy and diagnostic solutions that overlap with Cellavision's digital cell imaging and analysis market.
Agilon Health
AGL
Mkt Cap1.36B
Agilent Technologies offers a range of analytical instruments, including cell analysis solutions that compete with Cellavision's digital microscopy in the life sciences and diagnostics sectors.
Thermo Fisher Scientific
TMO
Mkt Cap166.59B
Thermo Fisher Scientific offers a broad range of analytical and diagnostic equipment, including cell imaging systems that compete with Cellavision's offerings.
Resmed
RMD
Mkt Cap30.18B
ResMed, while primarily focused on sleep and respiratory markets, has ventured into health informatics and diagnostic software that could indirectly compete with Cellavision's digital analysis tools.
Illumina
ILMN
Mkt Cap21.85B
Illumina, known for its genetic variation and function systems, also offers imaging and analysis solutions that could compete with Cellavision in genomics and pathology markets.
Guardant Health
GH
Mkt Cap12.59B
Guardant Health, primarily focused on liquid biopsy, also develops digital and analytical tools for cancer diagnostics, potentially competing with Cellavision's imaging and analysis technologies.

About

CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.
Show more...
CEO
Country
Sweden
ISIN
SE0000683484

Listings

0 Comments

Share your thoughts

FAQ

What is Cellavision AB stock price today?
The current price of C26.STU is €11.02 EUR — it has decreased by -1.96% in the past 24 hours. Watch Cellavision AB stock price performance more closely on the chart.
What is Cellavision AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cellavision AB stocks are traded under the ticker C26.STU.
Is Cellavision AB stock price growing?
C26.STU stock has fallen by -0.18% compared to the previous week, the month change is a -4.51% fall, over the last year Cellavision AB has showed a -34.56% decrease.
When is the next Cellavision AB earnings date?
Cellavision AB is going to release the next earnings report on July 17, 2026.
What were Cellavision AB earnings last quarter?
C26.STU earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.14 EUR resulting in a -40.41% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Cellavision AB pay dividends?
Yes, C26.STU dividends are paid annual. The last dividend per share was 0.25 EUR. As of today, Dividend Yield (FWD)% is 2.3%.
In which sector is Cellavision AB located?
Cellavision AB operates in the Other sector.
When did Cellavision AB complete a stock split?
Cellavision AB has not had any recent stock splits.